Jul 11, 2025, 15:03

Clinician-Scientist Start-Up Stipend

The University of Toronto Department of Medicine offers a five-year, $40,000 CAD per year start-up stipend to newly recruited Clinician Scientists at the Assistant Professor level. This funding optimizes early-career success by providing protected resources for salary support through the faculty member’s practice plan.

Eligibility Criteria:

Full-time clinical faculty appointed as Clinician Scientist (Assistant Professor) via external search.
Transitioning Clinician Investigators may apply within the first five years of their original appointment, with remaining years of eligibility.
Ineligible if appointed with an endowed or limited-term chair/professorship, alternate physician funding arrangement (e.g., Medical Oncology APP), or peer-review salary award ≥ $40K/year at appointment.
Must maintain Clinician Scientist status and not receive external salary support ≥ $40K/year; otherwise funding stops or is topped up by $10K/year (pro-rated) if external support ≥ $40K/year.

Funding Details:

Amount: $40,000 CAD annually for up to five years, paid to the individual’s practice plan.
If external salary support ≥ $40K/year is awarded during the term, DoM funding pauses or provides a $10K/year top-up (pro-rated).
Leave of absence (e.g., parental leave) may suspend and resume support.
Recipients are expected to apply for external salary awards within years 3–5.

Deadline:

Ongoing—funding commences on appointment start date and continues for five years, subject to eligibility.

Where to Go for Further Information:

Contact the Department of Medicine Research Administrator [email protected]

assistant professor funding cancer career development clinician scientist Department of Medicine OncoDaily Oncology start-up stipend University of Toronto

King Albert II’s Brave Battle: A Decade of Fighting Skin Cancer

25 Posts Not To Miss From ESMO GI 2025

Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update

Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career

Vivek Subbiah: It’s Time We Evolve WHO Cancer Classification